Lam Research Balance Sheet Health
Financial Health criteria checks 6/6
Lam Research has a total shareholder equity of $8.5B and total debt of $5.0B, which brings its debt-to-equity ratio to 58.8%. Its total assets and total liabilities are $19.5B and $11.1B respectively. Lam Research's EBIT is $4.6B making its interest coverage ratio -57.7. It has cash and short-term investments of $6.1B.
Key information
58.8%
Debt to equity ratio
US$4.98b
Debt
| Interest coverage ratio | -57.7x |
| Cash | US$6.07b |
| Equity | US$8.47b |
| Total liabilities | US$11.06b |
| Total assets | US$19.53b |
Recent financial health updates
Lam Research (NASDAQ:LRCX) Seems To Use Debt Quite Sensibly
Oct 12
Here's Why Lam Research (NASDAQ:LRCX) Can Manage Its Debt Responsibly
Jun 06Lam Research (NASDAQ:LRCX) Has A Pretty Healthy Balance Sheet
Jan 28Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Sep 27Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Jun 29Recent updates
Lam Research (NASDAQ:LRCX) Knows How To Allocate Capital Effectively
Nov 14Why Lam Research Is At A Make-Or-Break Level Before Earnings
Oct 22Lam Research (NASDAQ:LRCX) Seems To Use Debt Quite Sensibly
Oct 12Lam Research Following Micron's Footsteps In High Bandwidth Memory And Semiconductor Equipments Demand
Oct 11Lam Research: The Recent Pullback Is A Buying Opportunity
Sep 16Is Lam Research Corporation (NASDAQ:LRCX) Trading At A 36% Discount?
Sep 15Lam Research's (NASDAQ:LRCX) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 03Lam Research: Finding Opportunity Amidst Q4 FY 2024 Post Earnings Dip
Aug 16Lam Research: China Risk May Offset Memory Recovery And AI Boost
Aug 03The Lam Research Corporation (NASDAQ:LRCX) Full-Year Results Are Out And Analysts Have Published New Forecasts
Aug 02Investors Still Waiting For A Pull Back In Lam Research Corporation (NASDAQ:LRCX)
Jul 28Lam Research: It's Still All About Memory- Maintaining Buy
Jul 11Why Lam Research Corporation (NASDAQ:LRCX) Could Be Worth Watching
Jul 03Capitalizing On The Semiconductor Rebound: Lam Research Is A Compelling Buy
Jul 02Lam Research: Headwinds Coming From Chinese And Japanese Competitors
Jun 07Here's Why Lam Research (NASDAQ:LRCX) Can Manage Its Debt Responsibly
Jun 06Lam Research (NASDAQ:LRCX) Is Aiming To Keep Up Its Impressive Returns
May 23Lam Research: More Wafer Fab Equipment Spend For FY2025, Maintaining Buy
May 18Lam Research Corporation Just Beat EPS By 5.7%: Here's What Analysts Think Will Happen Next
Apr 26Lam Research: Benefiting From HBM-Driven DRAM; Initiate With 'Strong Buy'
Apr 18Lam Research: A Favorite In The Semis - Initiating With A Buy
Apr 09Why We're Not Concerned About Lam Research Corporation's (NASDAQ:LRCX) Share Price
Apr 04Lam Research: Stock Price Runup Justified But Upside Now Limited
Feb 24Here's What's Concerning About Lam Research's (NASDAQ:LRCX) Returns On Capital
Feb 22Investors Can Find Comfort In Lam Research's (NASDAQ:LRCX) Earnings Quality
Feb 09Lam Research Corporation (NASDAQ:LRCX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$872
Jan 31Lam Research (NASDAQ:LRCX) Has A Pretty Healthy Balance Sheet
Jan 28Lam Research: Lack Of Clarity On NAND A Significant Headwind In 2024
Jan 25Lam Research: Positioned Strongly (And Expensively) For AI Secular Trends
Jan 17Lam Research Corporation (NASDAQ:LRCX) Shares Could Be 25% Above Their Intrinsic Value Estimate
Jan 02Lam Research Corporation's (NASDAQ:LRCX) Price Is Out Of Tune With Earnings
Dec 21Why Lam Research Corporation (NASDAQ:LRCX) Could Be Worth Watching
Dec 09Lam Research (NASDAQ:LRCX) Might Become A Compounding Machine
Nov 15Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Sep 27A Look At The Fair Value Of Lam Research Corporation (NASDAQ:LRCX)
Aug 30Why Lam Research Corporation (NASDAQ:LRCX) Could Be Worth Watching
Aug 17Lam Research (NASDAQ:LRCX) Could Become A Multi-Bagger
Jul 10Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Jun 29If EPS Growth Is Important To You, Lam Research (NASDAQ:LRCX) Presents An Opportunity
Jun 07A Look At The Intrinsic Value Of Lam Research Corporation (NASDAQ:LRCX)
May 16Is It Too Late To Consider Buying Lam Research Corporation (NASDAQ:LRCX)?
May 05Financial Position Analysis
Short Term Liabilities: LRCX's short term assets ($13.5B) exceed its short term liabilities ($5.3B).
Long Term Liabilities: LRCX's short term assets ($13.5B) exceed its long term liabilities ($5.7B).
Debt to Equity History and Analysis
Debt Level: LRCX has more cash than its total debt.
Reducing Debt: LRCX's debt to equity ratio has reduced from 89.5% to 58.8% over the past 5 years.
Debt Coverage: LRCX's debt is well covered by operating cash flow (105.7%).
Interest Coverage: LRCX earns more interest than it pays, so coverage of interest payments is not a concern.